Is vitreous humour useful for the interpretation of 3,4-methylenedioxymethamphetamine (MDMA) blood levels? Experimental approach with rabbits

被引:35
作者
De Letter, EA
De Paepe, P
Clauwaert, KM
Belpaire, FM
Lambert, WE
Van Bocxlaer, JF
Piette, MHA
机构
[1] State Univ Ghent, Dept Forens Med, B-9000 Ghent, Belgium
[2] State Univ Ghent, Heymans Inst Pharmacol, B-9000 Ghent, Belgium
[3] State Univ Ghent, Dept Toxicol, B-9000 Ghent, Belgium
关键词
3,4-methylenedioxymethamphetamine; MDMA; vitreous humour; pharmacokinetics; post-mortem stability; rabbits;
D O I
10.1007/s004140000135
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
As drug instability and redistribution are factors known to affect the interpretation of post-mortem blood levels, we questioned whether post-mortem vitreous humour concentrations could be useful as predictors for the MDMA load at the time of death. In a first series of in vivo experiments using rabbits, 3,4-methylenedioxymethamphetamine (MDMA) concentrations in plasma, blood and vitreous humour were studied as a function of time after intravenous (iv) administration of MDMA. Equilibration between the vascular compartment and vitreous humour was attained about 1 h after iv MDMA administration. In a second series of experiments, the postmortem stability of MDMA in vitreous humour in relation to ambient temperature was investigated. Post-mortem MDMA concentrations in vitreous humour were closer to the ante-mortem blood levels when compared to cardiac blood samples. These preliminary investigations in the rabbit model indicate that measurements of vitreous humour concentrations could also be of interest for predicting the blood concentration at the time of death in humans.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 50 条
[41]   CHRONIC 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) USE - EFFECTS ON MOOD AND NEUROPSYCHOLOGICAL FUNCTION [J].
KRYSTAL, JH ;
PRICE, LH ;
OPSAHL, C ;
RICAURTE, GA ;
HENINGER, GR .
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 1992, 18 (03) :331-341
[42]   REVIEW OF THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY) [J].
GREEN, AR ;
CROSS, AJ ;
GOODWIN, GM .
PSYCHOPHARMACOLOGY, 1995, 119 (03) :247-260
[43]   3,4-Methylenedioxymethamphetamine (MDMA), but not morphine, alters APP processing in the rat brain [J].
Kalman, Janos ;
Bjelik, Annamaria ;
Hugyecz, Marietta ;
Timar, Julia ;
Gyarmati, Zsuzsanna ;
Zana, Marianna ;
Furst, Zsuzsanna ;
Janka, Zoltan ;
Rakonczay, Zoltan ;
Horvath, Zoltan ;
Pakaski, Magdona .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (02) :183-190
[44]   Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in the Netherlands [J].
van Deursen, M. M. ;
Lock, E. R. A. ;
Meer, A. J. Poortman-van der .
SCIENCE & JUSTICE, 2006, 46 (03) :135-152
[45]   The hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) is sensitive to sex differences [J].
Wyeth, Richard P. ;
Mills, Edward M. ;
Ullman, Alison ;
Kenaston, M. Alexander ;
Burwell, Johanna ;
Sprague, Jon E. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 235 (01) :33-38
[46]   MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves [J].
Parrott, AC .
NEUROPSYCHOBIOLOGY, 2004, 50 (04) :329-335
[47]   3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings [J].
Baumann, Michael H. ;
Wang, Xiaoying ;
Rothman, Richard B. .
PSYCHOPHARMACOLOGY, 2007, 189 (04) :407-424
[48]   Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons [J].
Gudelsky, Gary A. ;
Yamamoto, Bryan K. .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2008, 90 (02) :198-207
[49]   The effects of mirtazapine and fluoxetine on hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats [J].
Kasai, Makiko ;
Shioda, Katsutoshi ;
Nisijima, Koichi ;
Yoshino, Tatsuki ;
Iwamura, Tatsunori ;
Kato, Satoshi .
NEUROSCIENCE LETTERS, 2011, 499 (01) :24-27
[50]   Functional Consequences of Repeated (±)3,4-Methylenedioxymethamphetamine (MDMA) Treatment in Rhesus Monkeys [J].
Michael A Taffe ;
Michael R Weed ;
Sophia Davis ;
Salvador Huitrón-Resendiz ;
Richard Schroeder ;
Loren H Parsons ;
Steven J Henriksen ;
Lisa H Gold .
Neuropsychopharmacology, 2001, 24 :230-239